Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00307931
Status:
TERMINATED
Last Update Posted:
2011-08-31
First Post:
2006-03-24
Brief Title:
Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohns Disease Who Failed Infliximab
Sponsor:
Organization:
UCB Pharma